Clene, Inc. (CLNN)
4.435
+0.12
(+2.66%)
USD |
NASDAQ |
Aug 24, 16:00
4.435
0.00 (0.00%)
After-Hours: 20:00
Clene Market Cap : 56.67M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 55.20M |
| August 20, 2026 | 55.84M |
| August 19, 2026 | 53.54M |
| August 18, 2026 | 52.26M |
| August 17, 2026 | 53.67M |
| August 14, 2026 | 52.90M |
| August 13, 2026 | 53.54M |
| August 12, 2026 | 52.01M |
| August 11, 2026 | 55.84M |
| August 10, 2026 | 60.78M |
| August 07, 2026 | 62.19M |
| August 06, 2026 | 62.90M |
| August 05, 2026 | 63.37M |
| August 04, 2026 | 62.19M |
| August 03, 2026 | 61.13M |
| July 31, 2026 | 59.07M |
| July 30, 2026 | 59.36M |
| July 29, 2026 | 55.59M |
| July 28, 2026 | 58.77M |
| July 27, 2026 | 64.31M |
| July 24, 2026 | 63.48M |
| July 23, 2026 | 64.55M |
| July 22, 2026 | 68.55M |
| July 21, 2026 | 68.90M |
| July 20, 2026 | 67.49M |
| Date | Value |
|---|---|
| July 17, 2026 | 69.73M |
| July 16, 2026 | 67.02M |
| July 15, 2026 | 70.91M |
| July 14, 2026 | 72.91M |
| July 13, 2026 | 75.26M |
| July 10, 2026 | 73.85M |
| July 09, 2026 | 73.61M |
| July 08, 2026 | 71.61M |
| July 07, 2026 | 72.08M |
| July 06, 2026 | 70.79M |
| July 02, 2026 | 71.85M |
| July 01, 2026 | 72.20M |
| June 30, 2026 | 72.50M |
| June 29, 2026 | 74.62M |
| June 26, 2026 | 71.38M |
| June 25, 2026 | 68.20M |
| June 24, 2026 | 67.61M |
| June 23, 2026 | 67.96M |
| June 22, 2026 | 69.37M |
| June 18, 2026 | 70.79M |
| June 17, 2026 | 69.85M |
| June 16, 2026 | 68.90M |
| June 15, 2026 | 67.96M |
| June 12, 2026 | 68.79M |
| June 11, 2026 | 65.13M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovelStem International Corp. | 0.4687M |
| Brainstorm Cell Therapeutics, Inc. | 10.81M |
| Summit Therapeutics, Inc. | 10.09B |
| Kezar Life Sciences, Inc. | 53.76M |
| Protara Therapeutics, Inc. | 229.25M |
Market Cap Related Metrics
| PS Ratio | 252.11 |
| PEG Ratio | -0.0359 |
| Price | 4.435 |
| Earnings Yield | -79.20% |
| PEGY Ratio | -0.0359 |